Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q24240029)
Watch
English
Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease
scientific article
In more languages
edit
Statements
instance of
scholarly article
0 references
meta-analysis
0 references
review article
1 reference
stated in
Europe PubMed Central
title
Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease
(English)
0 references
main subject
chronic obstructive pulmonary disease
0 references
bronchitis
1 reference
based on heuristic
inferred from title
author
Phillippa Poole
series ordinal
1
0 references
Peter Black
series ordinal
2
object named as
Peter N Black
0 references
publication date
17 February 2010
0 references
published in
Cochrane Database of Systematic Reviews
0 references
cites work
Simpson's paradox and calculation of number needed to treat from meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
21 January 2018
Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immuno
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
21 January 2018
Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cost-effectiveness analysis of oral N-acetylcysteine as a preventive treatment in chronic bronchitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral Fabrol (oral N-acetyl-cysteine) in chronic bronchitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Assessing the quality of reports of randomized clinical trials: is blinding necessary?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
N‐isobutyrylcysteine, a donor of systemic thiols, does not reduce the exacerbation rate in chronic bronchitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of long-term treatment with sobrerol on the exacerbations of chronic bronchitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and tolerability of oral acetylcysteine (Fabrol) in chronic bronchitis: a double-blind placebo controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Iodinated glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
S-carboxymethylcysteine in the fluidification of sputum and treatment of chronic airway obstruction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Summary of the National Mucolytic Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F14651858.CD001287.PUB3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/14651858.CD001287.PUB3
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
4183839
OpenCitations bibliographic resource ID
4183839
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
4183839
PubMed publication ID
20166060
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
4183839
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
